Proposed warning statements for substances (eg, allergens) in medicines that may cause undesirable reactions

Response 295847848

Back to Response listing

Your details

3. Are you providing feedback:

Please select one item
Ticked As an individual
On behalf of an organisation or group

4. Where are you or your organisation based?

Please select one item
Ticked New Zealand
Australia
Other

5. Which of the below options best describes you in the context of this consultation?

Please select one item
Healthcare professional
Ticked Member of the public
Sponsor
Manufacturer
Supplier
Importer
Government organisation
Researcher
Professional body
Industry organisation
Consumer organisation
Institution (eg, university, hospital)
Regulatory affairs consultant
Laboratory professional
Other

Gluten

1. Should labels include a warning statement for gluten?

Please select one item
Ticked Yes
No

2. Do you agree with the inclusions (Ingredient derived from gluten-containing grain, Wheat starch)?

Please select one item
Ticked Yes
No

3. Do you agree with the proposed conditions for gluten?

Please select one item
Yes
Ticked No
If no, please suggest alternative conditions
Application to mucous membrane substances could potentially include the mouth. If a gluten containing medication was applied to a Coeliac orally they would ingest it and suffer damage, best to label oral application products.
In NZ 20 ppm does not qualify as gluten free, only gluten not detectable. Better than nothing but this proposed level will not be in line with NZ food labelling standards.

4. Do you agree with the proposed statement for gluten?

Please select one item
Ticked Yes
No
If no, please suggest an alternative statement
Very useful, as an ex nurse in a practical setting the ingredient information is not readily (or rapidly available) when dispensing meds.
This will alert staff and be able to prevent gluten exposure (and it's repercussions) for Coeliacs and gluten intolerant patients.